- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Thousands of scientists in the Russian Academy of Sciences (RAS) are about to lose their jobs as a result of the...
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
Senate Panel Approves $100 Million Boost for NIH in 2013
15 June 2012 3:17 pm
The Senate Appropriations Committee yesterday approved a modest $100 million raise for the National Institutes of Health (NIH) in the 2013 fiscal year which begins on 1 October. The 0.3% bump to a total of $30.723 billion is slightly better than the president's request for no increase, but it is disappointing to the research community.
The bill funding NIH provides $40 million for the Cures Acceleration Network, four times its current budget (but $10 million below the president's request). But it rejects a proposal by the president to cut $50 million from the Institutional Development Award (IDeA) program, which seeks to give institutions in poorer states a better shot at NIH funding. Instead, the committee would maintain funding at about $276 million. "The Committee believes the IDeA program has made a significant contribution to biomedical research and creating a skilled workforce," it notes in a report accompanying the bill. It also urges NIH to expand the number of schools eligible for the program.
The committee did back a requested $28 million trim, to $165 million, for the National Children's Study (NCS), an ambitious but troubled federal plan to follow the health of 100,000 children from before birth to age 21. The panel hopes the 15% cut "represents a positive sign that NIH intends to bring the costs of the NCS under control and spend its appropriation more efficiently," it writes in the report. "The Committee is troubled that after appropriating nearly [$1 billion] for the NCS since the first work on it began in fiscal year 2000, only a few thousand children have been enrolled and fundamental questions about the project's implementation still remain, particularly regarding the methods that will be used to recruit participants." The panel also wants the National Academy of Sciences to review NCS's statistical sampling strategy and for NIH to "improve its level of communication with the research community about any future changes to the project."
On the subject of Alzheimer's disease, the panel chastised NIH officials for plans to boost research in the field by snagging $80 million from a $500 million Prevention and Public Health (PPH) Fund created by health care reform legislation. "NIH research is not an appropriate use of the PPH Fund," it wrote. "Additionally, the Committee believes it would set a dangerous precedent to provide specific amounts of NIH funding for individual diseases. The Committee notes that it took the same position in fiscal year 2010 when the administration proposed allocating specific levels of funding for cancer and autism research."
The bill must still be approved by the full Senate. The House appropriations panel has yet to introduce its version of the bill.